Anika Therapeutics, Inc.
ANIK
$14.36
$0.161.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 101.34% | -- | -4,411.36% | -7.95% | 65.29% |
| Total Depreciation and Amortization | -8.09% | -- | -38.44% | -22.83% | 127.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -82.94% | -- | 26.86% | -47.42% | -67.23% |
| Change in Net Operating Assets | 52.14% | -- | 52.34% | 93.56% | 9.50% |
| Cash from Operations | 193.11% | 36.96% | 82.32% | -3.17% | -56.51% |
| Capital Expenditure | 50.42% | -- | 56.89% | -56.19% | 28.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 115.15% | 4.63% | 84.16% | 192.48% | 28.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -19.53% | -- | -43.75% | -- | -11.34% |
| Repurchase of Common Stock | 2.35% | -- | 94.79% | -136.85% | -80,828.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.40% | 99.67% | 116.11% | -139.24% | -1,665.50% |
| Foreign Exchange rate Adjustments | 50.00% | -- | 254.02% | 448.39% | -271.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 90.23% | 1,162.33% | 96.49% | 10.62% | -335.06% |